Behavioral Variant Frontotemporal Dementia (bvFTD) Clinical Trials

12 clinical trials for Behavioral Variant Frontotemporal Dementia (bvFTD) across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) — RECRUITING
• Tracking and Predicting How Brain Damage Spreads in Neurodegenerative Diseases — RECRUITING · NA
• Diagnosing Frontotemporal Lobar Degeneration — RECRUITING
• Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System — COMPLETED · NA
• Neuroinflammation in FTLD — ACTIVE_NOT_RECRUITING
• The Ketogenic Diet in the Treatment of Behavioral Variant Frontotemporal Dementia — NOT_YET_RECRUITING · NA
• Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD) — TERMINATED · PHASE3
• Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) — COMPLETED
• Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD) — COMPLETED
• Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) — COMPLETED · PHASE3
• AN OPEN-LABEL, EXTENSION STUDY OF THE EFFECTS OF LEUCO-METHYLTHIONINIUM BIS(HYDROMETHANESULFONATE) IN SUBJECTS WITH ALZHEIMER'S DISEASE OR BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA — COMPLETED
• A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, PARALLEL GROUP, 12-MONTH SAFETY AND EFFICACY TRIAL OF LEUCO-METHYLTHIONINIUM BIS(HYDROMETHANESULFONATE) IN SUBJECTS WITH BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA (BVFTD) — COMPLETED

Refine this search